Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes

Journal of Clinical Investigation

Volumn 102, Issue 11, 1998, Pages 1895-1899

  Steinsapir, Jaime ^a   Harney, John ^a   Larsen, P Reed ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

MG132; Reverse T3; Selenium; Selenocysteine; Thyroid hormone metabolism

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHLOROQUINE; CYCLOHEXIMIDE; CYTOCHALASIN B; PROTEASOME; SELENIUM; SELENOCYSTEINE; THYROXINE DEIODINASE;

ACTIN POLYMERIZATION; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; ENZYME INACTIVATION; ENZYME SUBSTRATE; HALF LIFE TIME; HYPOPHYSIS TUMOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RECEPTOR BLOCKING; THYROID HORMONE METABOLISM; TRANSLATION REGULATION;

EID: 0032423089     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4672     Document Type: Article

References (30)

1. Larsen, P.R., J.E. Silva, and M.M. Kaplan. 1981. Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr. Rev. 2:87-102.
2. Silva, J.E., and P.R. Larsen. 1977. Pituitary nuclear 3,5,3′-triiodothyronine and thyrotropin secretion: an explanation for the effect of thyroxine. Science. 198:617-620.
3. Silva, J.E., J.L. Leonard, F.R. Crantz, and P.R. Larsen. 1982. Evidence for two tissue specific pathways for in vivo thyroxine 5′ deiodination in the rat. J. Clin. Invest. 69:1176-1184.
4. Silva, J.E., and P.R. Larsen. 1982. Comparison of iodothyronine 5′-deiodinase and other thyroid-hormone-dependent enzyme activities in the cerebral cortex of hypothyroid neonatal rat: evidence for adaptation to hypothyroidism. J. Clin. Invest. 70:1110-1123.
5. Leonard, J.L., J.E. Silva, M.M. Kaplan, S.A. Mellen, T.J. Visser, and P.R. Larsen. 1984. Acute post-transcriptional regulation of cerebrocortical and pituitary iodothyroinine 5′-deiodinase by thyroid hormone. Endocrinology. 114: 998-1004.
6. Silva, J.E., and J.L. Leonard. 1985. Regulation of rat cerebrocortical and adenohypophyseal type II 5′-deiodinase by thyroxine, triiodothyronine, and reverse triiodothyronine. Endocrinology. 116:1627-1635.
7. Obregon, M.J., P.R. Larsen, and J.E. Silva. 1986. The role of 3,3′5′-triiodothyronine in the regulation of Type II iodothyronine 5′-deiodinase in the rat cerebral cortex. Endocrinology. 119:2186-2192.
8. St. Germain, D.L. 1988. The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5′-deiodinase. Endocrinology. 122:1860-1868.
9. Visser, T.J., M.M. Kaplan, J.L. Leonard, and P.R. Larsen. 1983. Evidence for two pathways of iodothyronine 5′-deiodination in rat pituitary that differ in kinetics, propylthiouracil sensitivity, and response to hypothyroidism. J. Clin. Invest. 71:992-1002.
10. Koenig, R.J. 1986. Regulation of thyroxine 5′-dciodinase by thyroid hormones and activators of protein kinase C in GH4C1 cells. Endocrinology. 118:1491-1497.
11. Croteau, W., J.C. Davey, V.A. Galton, and D.L. St. Germain. 1996. Cloning of the mammalian Type II iodothyronine deiodinase: a selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J. Clin. Invest. 98:405-417.
12. Tu, H.M., S.W. Kim, D. Salvatore, T. Bartha, G. Legradi, P.R. Larsen, and R.M. Lechan. 1997. Regional distribution of type 2 thyroxine deiodinase messenger ribonucleic acid in rat hypothalamus and pituitary and its regulation by thyroid hormone. Endocrinology. 138:3359-3368.
13. Leonard, J.L., and P.R. Larsen. 1985. Thyroid hormone metabolism in primary cultures of fetal rat brain cells. Brain. Res. 327:1-13.
14. Farwell, A.P., and J.L. Leonard. 1989. Identification of a 27-kDa protein with the properties of type II iodothyronine 5′-deiodinase in dibutyryl cyclic AMP-stimulated glial cells. J. Biol. Chem. 264:20561-20567.
15. Leonard, J.L., C.A. Siegrist-Kaiser, and C.J. Zuckerman. 1990. Regulation of type II iodothyronine 5′-deiodinase by thyroid hormone. Inhibition of actin polymerization blocks enzyme inactivation in cAMP-stimulated glial cells. J. Biol. Chem. 265:940-946.
16. Coux, O., K. Tanaka, and A.L. Goldberg. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
17. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:761-771.
18. Koenig, R.J., J.L. Leonard, D. Senator, N. Rappaport, A.Y. Watson, and P.R. Larsen. 1984. Regulation of thyroxine 5′-deiodinase activity by T3 in cultured rat anterior pituitary cells. Endocrinology. 115:324-329.
19. Berry, M.J., A.L. Kates, and P.R. Larsen. 1990. Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Mol. Endocrinol. 4:743-748.
20. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.
21. Salvatore, D., T. Bartha, J.W. Harney, and P.R. Larsen. 1996. Molecular biological and biochemical characterization of the human Type 2 selenodeiodinase. Endocrinology. 137:3308-3315.
22. Tawa, N.E., Jr., R. Odessey, and A.L. Goldberg. 1997. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:197-203.
23. Tawa, N.E., Jr., I.C. Kettelhut, and A.L. Goldberg. 1992. Dietary protein deficiency reduces lysosomal and nonlysosomal ATP-dependent proteolysis in muscle. Am. J. Physiol. 263:E326-E334.
24. Jensen, T.J., M.A. Loo, S. Pind, D.B. Williams, A.L. Goldberg, and J.R. Riordan. 1995. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell. 83:129-135.
25. Lee, D.H., and A.L. Goldberg. 1996. Selective inhibitors of the proteasome-dependent and vacuolar pathways of protein degradation in Saccharomyces cerevisiae. J. Biol. Chem. 271:27280-27284.
26. St. Germain, D.L. 1986. Hormonal control of a low Km (type II) iodothyronine 5′-deiodinase in cultured NB41A3 mouse neuroblastoma cells. Endocrinology. 119:840-346.
27. Halperin, Y., L.E. Shapiro, and M.I. Surks. 1994. Down-regulation of type II L-thyroxine, 5′-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3′,5′-triiodo-L-thyronine. Endocrinology. 135:1464-1469.
28. Burmeister, L.A., J. Pachucki, and D.L. St. Germain. 1997. Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology. 138:5231-5237.
29. Leonard, J.L., M.M. Kaplan, T.J. Visser, J.E. Silva, and P.R. Larsen. 1981. Cerebral cortex responds rapidly to thyroid hormones. Science. 214:571-573.
30. LoPresti, J.S., A. Eigen, E. Kaptein, K.P. Anderson, C.A. Spencer, and J.T. Nicoloff. 1989. Alterations in 3,3′,5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. J. Clin. Invest. 84:1650-1656.